253 - Upstairs and Downstairs: Updates on Human Papilloma Virus Screening

Wednesday, October 22, 2025

1:45 PM - 3:00 PM US ET

Location: B206

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

David Gaston, MD PhD

Assistant Professor, Medical Director (Molecular Infectious Disease Laboratory)
Vanderbilt University Medical Center
Nashville, TN, United States
EC

Elizabeth Chiao, MD, MPH

University of Texas MD Anderson Cancer Center
Houston, Texas, United States

Faculty(s)

Helen Stankiewicz Karita, MD, MSc (she/her/hers)

Associate Clinical Professor of Medicine
University of California San Francisco
San Francisco, CA, United States
Krystle Lang Kuhs, PhD, MPH (she/her/hers)

Associate Professor
University of Kentucky
Lexington, KY, United States
Susan Cu-Uvin, MD (she/her/hers)

Professor Ob-Gyn and Medicine
Brown University
Providence, RI, United States

Disclosure(s):

David C. Gaston, MD PhD: American Society of Microbiology: Honoraria; Biomerieux/Biofire diagnositcs: Honoraria; DiaSorin: Honoraria; QuidelOrtho: Honoraria; Roche Diagnostics: Honoraria; T2Biosystems: Grant/Research Support

Elizabeth Chiao, MD, MPH: No financial relationships to disclose.

Helen Stankiewicz Karita, MD, MSc: No financial relationships to disclose.

Krystle Lang Kuhs, PhD, MPH: No financial relationships to disclose.

Susan Cu-Uvin, MD: No financial relationships to disclose.

Learning Objectives:

At the conclusion of this session, participants will be able to:

summarize recent clinical data on screening, prevention, and treatment of HPV-driven malignancies;
explain diagnostic differences between oropharyngeal, cervical, and anal HPV testing;
describe current screening guidelines and determine gaps for ongoing development and progress.

Presentations:

1:45 PM - 2:10 PM US ET

Treatment Can Prevent Anal Cancer – the ANCHOR Study
Speaker: Helen Stankiewicz Karita, MD, MSc (she/her/hers) – University of California San Francisco
2:10 PM - 2:35 PM US ET

Recent Advances Toward Developing Screening for Oropharyngeal Cancer
Speaker: Krystle Lang Kuhs, PhD, MPH (she/her/hers) – University of Kentucky
2:35 PM - 3:00 PM US ET

Updates in HPV Cervical Screening, Pathology and Diagnostics
Speaker: Susan Cu-Uvin, MD (she/her/hers) – Brown University